India Neurological Disorder Drugs Market (2025-2031) | Growth, Industry, Share, Competitive Landscape, Segmentation, Forecast, Outlook, Value, Companies, Size & Revenue, Trends, Analysis
Market Forecast By Indication (Epilepsy, Alzheimers Disease, Parkinsons Disease, Multiple Sclerosis, Cerebrovascular Disease, Others), By Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Antiepileptic, Antipsychotic and Antidepressant, Others), By Route of Administration (Oral, Parenteral, Others), By End-Users (Hospitals, Specialty Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) And Competitive Landscape
| Product Code: ETC7548814 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
India Neurological Disorder Drugs Market Import Shipment Trend (2020-2024)
The India neurological disorder drugs market import shipment has shown remarkable growth from 2020-2024, with a staggering CAGR of 100.6%. The growth momentum remained strong, with a notable increase in the growth rate between 2023 and 2024 at 42.5%. The market clearly experienced significant expansion and robust upward trend during this period.
Key Highlights of the Report:
- India Neurological Disorder Drugs Market Outlook
- Market Size of India Neurological Disorder Drugs Market, 2024
- Forecast of India Neurological Disorder Drugs Market, 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Revenues & Volume for the Period 2021- 2031
- India Neurological Disorder Drugs Market Trend Evolution
- India Neurological Disorder Drugs Market Drivers and Challenges
- India Neurological Disorder Drugs Price Trends
- India Neurological Disorder Drugs Porter's Five Forces
- India Neurological Disorder Drugs Industry Life Cycle
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By Indication for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By Epilepsy for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By Alzheimers Disease for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By Parkinsons Disease for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By Multiple Sclerosis for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By Cerebrovascular Disease for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By Others for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By Drug Class for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By Cholinesterase Inhibitors for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By NMDA Receptor Antagonists for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By Antiepileptic for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By Antipsychotic and Antidepressant for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By Others for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By Route of Administration for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By Oral for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By Parenteral for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By Others for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By End-Users for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By Hospitals for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By Specialty Clinics for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By Homecare for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By Others for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By Hospital Pharmacy for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By Retail Pharmacy for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By Online Pharmacy for the Period 2021- 2031
- Historical Data and Forecast of India Neurological Disorder Drugs Market Revenues & Volume By Others for the Period 2021- 2031
- India Neurological Disorder Drugs Import Export Trade Statistics
- Market Opportunity Assessment By Indication
- Market Opportunity Assessment By Drug Class
- Market Opportunity Assessment By Route of Administration
- Market Opportunity Assessment By End-Users
- Market Opportunity Assessment By Distribution Channel
- India Neurological Disorder Drugs Top Companies Market Share
- India Neurological Disorder Drugs Competitive Benchmarking By Technical and Operational Parameters
- India Neurological Disorder Drugs Company Profiles
- India Neurological Disorder Drugs Key Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
6Wresearch actively monitors the India Neurological Disorder Drugs Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the India Neurological Disorder Drugs Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Neurological Disorder Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Neurological Disorder Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Neurological Disorder Drugs Market - Industry Life Cycle |
3.4 India Neurological Disorder Drugs Market - Porter's Five Forces |
3.5 India Neurological Disorder Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 India Neurological Disorder Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 India Neurological Disorder Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 India Neurological Disorder Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 India Neurological Disorder Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Neurological Disorder Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in India |
4.2.2 Growing awareness about mental health and neurological conditions |
4.2.3 Technological advancements in drug development for neurological disorders |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in India |
4.3.2 High cost of neurological disorder drugs |
4.3.3 Limited access to healthcare facilities in rural areas |
5 India Neurological Disorder Drugs Market Trends |
6 India Neurological Disorder Drugs Market, By Types |
6.1 India Neurological Disorder Drugs Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 India Neurological Disorder Drugs Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 India Neurological Disorder Drugs Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.1.4 India Neurological Disorder Drugs Market Revenues & Volume, By Alzheimers Disease, 2021- 2031F |
6.1.5 India Neurological Disorder Drugs Market Revenues & Volume, By Parkinsons Disease, 2021- 2031F |
6.1.6 India Neurological Disorder Drugs Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.1.7 India Neurological Disorder Drugs Market Revenues & Volume, By Cerebrovascular Disease, 2021- 2031F |
6.1.8 India Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Neurological Disorder Drugs Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 India Neurological Disorder Drugs Market Revenues & Volume, By Cholinesterase Inhibitors, 2021- 2031F |
6.2.3 India Neurological Disorder Drugs Market Revenues & Volume, By NMDA Receptor Antagonists, 2021- 2031F |
6.2.4 India Neurological Disorder Drugs Market Revenues & Volume, By Antiepileptic, 2021- 2031F |
6.2.5 India Neurological Disorder Drugs Market Revenues & Volume, By Antipsychotic and Antidepressant, 2021- 2031F |
6.2.6 India Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Neurological Disorder Drugs Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 India Neurological Disorder Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 India Neurological Disorder Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 India Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Neurological Disorder Drugs Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 India Neurological Disorder Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 India Neurological Disorder Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 India Neurological Disorder Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.5 India Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 India Neurological Disorder Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 India Neurological Disorder Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 India Neurological Disorder Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 India Neurological Disorder Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.5 India Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 India Neurological Disorder Drugs Market Import-Export Trade Statistics |
7.1 India Neurological Disorder Drugs Market Export to Major Countries |
7.2 India Neurological Disorder Drugs Market Imports from Major Countries |
8 India Neurological Disorder Drugs Market Key Performance Indicators |
8.1 Number of clinical trials for new neurological disorder drugs in India |
8.2 Adoption rate of telemedicine and online healthcare services for neurological disorders |
8.3 Investment in research and development for innovative neurological disorder drugs in India |
9 India Neurological Disorder Drugs Market - Opportunity Assessment |
9.1 India Neurological Disorder Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 India Neurological Disorder Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 India Neurological Disorder Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 India Neurological Disorder Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 India Neurological Disorder Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Neurological Disorder Drugs Market - Competitive Landscape |
10.1 India Neurological Disorder Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Neurological Disorder Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Pricing
- Single User License$ 1,995
- Department License$ 2,400
- Site License$ 3,120
- Global License$ 3,795
Search
Thought Leadership and Analyst Meet
Our Clients
Related Reports
- Germany Breakfast Food Market (2026-2032) | Industry, Share, Growth, Size, Companies, Value, Analysis, Revenue, Trends, Forecast & Outlook
- Australia Briquette Market (2025-2031) | Growth, Size, Revenue, Forecast, Analysis, Trends, Value, Share, Industry & Companies
- Vietnam System Integrator Market (2025-2031) | Size, Companies, Analysis, Industry, Value, Forecast, Growth, Trends, Revenue & Share
- ASEAN and Thailand Brain Health Supplements Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
- ASEAN Bearings Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
- Europe Flooring Market (2025-2031) | Outlook, Share, Industry, Trends, Forecast, Companies, Revenue, Size, Analysis, Growth & Value
- Saudi Arabia Manlift Market (2025-2031) | Outlook, Size, Growth, Trends, Companies, Industry, Revenue, Value, Share, Forecast & Analysis
- Uganda Excavator, Crane, and Wheel Loaders Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
- Rwanda Excavator, Crane, and Wheel Loaders Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
- Kenya Excavator, Crane, and Wheel Loaders Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
Industry Events and Analyst Meet
Stationery & Paper Expo Saudi Arabia 2026
Kids & Toys Expo Saudi Arabia 2026
Gifts & Homeware Expo Saudi Arabia 2026
Smart Home Expo 2026
Industrial Facilities Management Expo 2025
Whitepaper
- Middle East & Africa Commercial Security Market Click here to view more.
- Middle East & Africa Fire Safety Systems & Equipment Market Click here to view more.
- GCC Drone Market Click here to view more.
- Middle East Lighting Fixture Market Click here to view more.
- GCC Physical & Perimeter Security Market Click here to view more.
6WResearch In News
- Doha a strategic location for EV manufacturing hub: IPA Qatar
- Demand for luxury TVs surging in the GCC, says Samsung
- Empowering Growth: The Thriving Journey of Bangladesh’s Cable Industry
- Demand for luxury TVs surging in the GCC, says Samsung
- Video call with a traditional healer? Once unthinkable, it’s now common in South Africa
- Intelligent Buildings To Smooth GCC’s Path To Net Zero
